Header Logo

Connection

Joan Lo to Osteoporosis

This is a "connection" page, showing publications Joan Lo has written about Osteoporosis.
Connection Strength

5.968
  1. Changing trends in bisphosphonate therapy: a twenty-five-year surveillance in a single US integrated healthcare system. Osteoporos Int. 2025 Apr; 36(4):741-747.
    View in: PubMed
    Score: 0.910
  2. Challenges of fracture risk assessment in Asian and Black women. Am J Manag Care. 2024 Mar; 30(3):140-144.
    View in: PubMed
    Score: 0.853
  3. Osteoporosis and Fracture Risk among Older US Asian Adults. Curr Osteoporos Rep. 2023 10; 21(5):592-608.
    View in: PubMed
    Score: 0.820
  4. The Epidemiology of Metatarsal Fractures Among Older Females With Bisphosphonate Exposure. J Foot Ankle Surg. 2020 Mar - Apr; 59(2):269-273.
    View in: PubMed
    Score: 0.646
  5. Vitamin D Status Among Older Women Initiating Osteoporosis Therapy. J Am Geriatr Soc. 2019 10; 67(10):2207-2208.
    View in: PubMed
    Score: 0.623
  6. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.555
  7. Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA. Osteoporos Int. 2016 12; 27(12):3477-3484.
    View in: PubMed
    Score: 0.504
  8. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
    View in: PubMed
    Score: 0.350
  9. How Should We Counsel Asian Americans about Fracture Risk? J Am Geriatr Soc. 2020 07; 68(7):1613-1614.
    View in: PubMed
    Score: 0.164
  10. Determinants of Oral Bisphosphonate Use Beyond 5 Years. J Manag Care Spec Pharm. 2020 Feb; 26(2):197-202.
    View in: PubMed
    Score: 0.161
  11. Using Pharmacy Data and Adherence to Define Long-Term Bisphosphonate Exposure in Women. J Manag Care Spec Pharm. 2019 Jun; 25(6):719-723.
    View in: PubMed
    Score: 0.153
  12. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.112
  13. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. J Oral Maxillofac Surg. 2012 Aug; 70(8):1844-53.
    View in: PubMed
    Score: 0.094
  14. Application of new method for evaluating performance of fracture risk tool. Am J Manag Care. 2012 Oct 01; 18(10):e398.
    View in: PubMed
    Score: 0.024

© 2025 Kaiser Permanente